Last modified on 27 August 2020, at 15:17

Right to Try Act

The Right to Try Act enables certain patients to access medication and treatments that have not been fully approved by the FDA. Signed into law by President Donald Trump in June 2018, the Right to Try Act was passed over the objections of Democrats, the FDA, and Big Pharma. House Representative Andy Biggs (R-AZ) and Senator Ron Johnson (R-WI) were leaders in enacting this populist legislation.

At the time of passage, right-to-try laws already existed in 38 states to protect patients and their physicians against retaliation by the states:[1]

Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, West Virginia, Washington and Wyoming.